relatlimab
-got-
-mar-
dulanermin
naxitamab
immunoproteomics
lucatumumab
cemiplimab
onartuzumab
immunizing
minretumomab
immunoscore
oncotropic
autoepitope
plerixafor
oregovomab
ramucirumab
milatuzumab
-les-
vepalimomab
sipuleucel
carlumab
immunovirological
brentuximab vedotin
amivantamab
potentiator
immunodoublestain
cixutumumab
immunotargeting
cedelizumab
teprotumumab
agonistic monoclonal antibody
tabalumab
nimotuzumab
immunofactor
guselkumab
tisotumab
matrilysin
ribociclib
immunotherapy
immunogenomic
necroenzyme
labetuzumab
immunoregulating
immunorelevant
immunopathology
monovaccine
immunotherapeutic
immunophelometric
immunoproteomic